ADAR1 Capital Management »

Guardant Health shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Guardant Health (GH) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Guardant Health

Tip: Access up to 7 years of quarterly data

All positions including Guardant Health held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Guardant Health by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.4M 117k 20.63

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Guardant Health

Vanguard Group
BlackRock
Baillie Gifford & Co
Cadian Capital Management
Eventide Asset Management
Citadel Advisors
Alliancebernstein
FMR
Parkwood
Geode Capital Management
Braidwell
Fil
Credit Suisse
Point72 Asset Management
T. Rowe Price Associates

View all funds holding Guardant Health